Experimental Surgery Research Group, General and Digestive Surgery Department, Arnau de Vilanova University Hospital, University of Lleida, 25716 Lleida, Spain.
Institut de Recerca Biomèdica Lleida (IRB-LLeida), 25198 Lleida, Spain.
Nutrients. 2023 May 22;15(10):2414. doi: 10.3390/nu15102414.
Adipocyte dysfunction is the driver of obesity and correlates with insulin resistance and the onset of type 2 diabetes. Protein kinase N1 (PKN1) is a serine/threonine kinase that has been shown to contribute to Glut4 translocation to the membrane and glucose transport. Here, we evaluated the role of PKN1 in glucose metabolism under insulin-resistant conditions in primary visceral adipose tissue (VAT) from 31 patients with obesity and in murine 3T3-L1 adipocytes. In addition, in vitro studies in human VAT samples and mouse adipocytes were conducted to investigate the role of PKN1 in the adipogenic maturation process and glucose homeostasis control. We show that insulin-resistant adipocytes present a decrease in PKN1 activation levels compared to nondiabetic control counterparts. We further show that PKN1 controls the adipogenesis process and glucose metabolism. PKN1-silenced adipocytes present a decrease in both differentiation process and glucose uptake, with a concomitant decrease in the expression levels of adipogenic markers, such as PPARγ, FABP4, adiponectin and CEBPα. Altogether, these results point to PKN1 as a regulator of key signaling pathways involved in adipocyte differentiation and as an emerging player of adipocyte insulin responsiveness. These findings may provide new therapeutic approaches for the management of insulin resistance in type 2 diabetes.
脂肪细胞功能障碍是肥胖的驱动因素,与胰岛素抵抗和 2 型糖尿病的发生相关。蛋白激酶 N1(PKN1)是一种丝氨酸/苏氨酸激酶,已被证明有助于 Glut4 向膜的易位和葡萄糖转运。在这里,我们评估了 PKN1 在肥胖症患者的 31 例原发性内脏脂肪组织(VAT)和鼠 3T3-L1 脂肪细胞中胰岛素抵抗条件下葡萄糖代谢中的作用。此外,在人 VAT 样本和鼠脂肪细胞的体外研究中,研究了 PKN1 在脂肪生成成熟过程和葡萄糖稳态控制中的作用。我们发现与非糖尿病对照组相比,胰岛素抵抗脂肪细胞的 PKN1 激活水平降低。我们进一步表明 PKN1 控制脂肪生成过程和葡萄糖代谢。沉默 PKN1 的脂肪细胞在分化过程和葡萄糖摄取方面均减少,同时脂肪生成标志物的表达水平降低,如 PPARγ、FABP4、脂联素和 CEBPα。总之,这些结果表明 PKN1 是参与脂肪细胞分化的关键信号通路的调节剂,也是脂肪细胞胰岛素反应性的新兴参与者。这些发现可能为 2 型糖尿病胰岛素抵抗的管理提供新的治疗方法。